1. lékařská fakulta Univerzity Karlovy Univerzita Karlova
Zajímá vás, co se děje na fakultě? Přihlaste se k odběru bulletinu Jednička.

Pomůžeme vám

Potřebujete pomoc nebo informace a nevíte přesně na koho se obrátit?

Kontaktujte nás

Přednáška High throughput synthesis and analysis of DNA and peptides

Srdečně Vás zveme na přednášku Ing. Michala Lebla, Ph.D., DrSc.: "High throughput synthesis and analysis of DNA and peptides", která se uskuteční 8. 3. 2018 v 10.00hodin v BIOCEVu (Průmyslová 595, Vestec Konferenční sál - U2.012). Více ZDE.

High throughput synthesis and analysis of DNA and peptides

  • kdy: 8. 3. 2018 - 8. 3. 2018 | 10.00
  • kde: BIOCEV, Průmyslová 595, Vestec - Czech Republic, mail conference hall (no. U2.012)


Ing. Michal Lebl, PhD., DSc.

  • 8. 3. 2018 – 10.00 – Conference Hall
“High throughput synthesis and analysis of DNA and peptides.”
Michal Lebl graduated from The University of Chemical Technology (VSCHT) in 1974. He finished his Ph.D. (CSc) studies at the Institute of Organic Chemistry and Biochemistry of the Czechoslovak Academy of Sciences in Prague in 1978, and he worked in this institute as a graduate student, scientist, and finally Department Head for 17 years.
In 1992 he defended his D.Sc. (Organic Chemistry) title in the same institution. At that time he was already working as the Director of Chemistry in Selectide Corporation, the first combinatorial chemistry company in the world, in Tucson, USA. Selectide developed the one-bead-one-compound technology that allows the simultaneous synthesis and screening of millions of organic compounds for their potential biological activity leading to the development of new drugs. Selectide was purchased by Marion-Merrel-Dow in 1995 and later by Hoechst. Michal Lebl decided to leave to build the Department of Automation at Houghten Pharmaceuticals, an early competitor of Selectide.
In 1993 he formed Spyder Instruments. This company was merged with the new startup biotech company Illumina Inc. in 2000, and Ing. Lebl worked there as Senior Director of Automation till 2012. In 2011 he moved to Prague and started the company Spyder Institut Praha dedicated to application of peptides in diagnostics and pharmaceuticals.
Presently he works back in his alma maters VSCHT and UOCHB as the head of the Development Center. Ing. Lebl is the recipient of several awards, the most prestigious being the Leonidas Zervas Award of the European Peptide Society. He has published more than 250 scientific articles, several books and his software Peptide Companion is installed on hundreds of computers worldwide. He is co-author of more than 50 patents and patent applications. Ing. Lebl received and sucessfully managed four NIH grants bringing to his labs in USA more than $3.5 million.



Hodnocení: spravovat